The spin-off RetinaReadRisk has been created for marketing software and a mobile system based on artificial intelligence to detect diabetic retinopathy in the early stages

...

21 March, 2023

GENESIS Biomed continues growing and adding value in biomedical sector

...

15 December, 2022

GENESIS Biomed receives the award for the best biomedical consultancy in the XI Edition of the National Awards El Suplemento

...

21 June, 2022

GENESIS Biomed and FI Group create GENESIS Tech Transfer Boost, a new investment vehicle that will invest in early stage projects from healthcare research

...

26 April, 2022

The Universidad Autónoma de Madrid launches a specific entrepreneurship programme for health researchers in collaboration with GENESIS Biomed

...

06 April, 2022

The European EIT Health-supported project Retina-Read-Risk will detect diabetic retinopathy through telemedicine

...

14 March, 2022

I3PT founds ANAIS Medical to bring professionals closer to highly realistic medical simulation for interventional procedures

...

17 January, 2022

GENESIS Biomed supports the creation of BetaScreen, the first spin-off of the Pasqual Maragall Foundation.

...

25 November, 2021

Opening of the Mowoot Crowdfunding campaign with the participation of EIT Health

...

10 November, 2021

Corify Care raises €2.35M to translate its cardiac mapping technology to the market

...

06 July, 2021